Regeneron Pharmaceuticals
An Associate Director in Global Development Quality Inspection Management (GDQIM) serving as an Inspection Management Lead. The role is focused on oversight of inspection readiness for GCP, GVP, and GLP across Regeneron's clinical development programs and acting as a cross-functional liaison between GDQIM and clinical study teams. The position supports enterprise-level quality and compliance activities within Global Development Quality.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Sr. Mgr Inspection Management
lifelancer
Associate Director, GCP QA
Mirum Pharmaceuticals
Director, GCP & GLP QA
Tango Therapeutics
Vice President, Quality
Sabin Vaccine Institute
Associate Director, Quality Systems & Compliance (GCP/GLP/GVP)
Revolution Medicines
Director, Development and Safety Quality
ardelyx